| Patent application number | Description | Published |
|---|
| 20090099105 | Content dependent inhibitors of cytidine deaminases and uses thereof - This invention relates to cytidine deaminase inhibitors (Cytidine deaminase inhibitors) of cytidine deaminases and uses thereof. | 04-16-2009 |
| 20100016253 | METHODS AND COMPOSITIONS RELATED TO HEIGHTENED APOBEC-1 RELATED PROTEIN (ARP) EXPRESSION - Disclosed are methods and compositions related to determining the status and mechanisms underlying long-term nonprogression of viral infections. | 01-21-2010 |
| 20100029570 | PEPTIDE AND TREATMENT FOR HIV-1 INFECTION - A compound of the formula X | 02-04-2010 |
| 20100100976 | METHODS AND COMPOSITIONS RELATED TO APOBEC-1 EXPRESSION - Disclosed are methods and compositions related to APOBEC-1. | 04-22-2010 |
| 20100160174 | PROTEIN TRANSDUCING DOMAIN/DEAMINASE CHIMERIC PROTEINS, RELATED COMPOUNDS, AND USES THEREOF - Disclosed are compositions for chimeric proteins comprising a protein transduction domain and a deaminase domain, mimetics or analog thereof, and uses of same. | 06-24-2010 |
| 20100197768 | METHODS AND COMPOSITIONS RELATED TO THE STRUCTURE AND FUNCTION OF APOBEC3G - Disclosed are methods and compositions related to the structure and function of APOBEC3G. | 08-05-2010 |
| 20100297219 | Methods and Compositions for Modifying Apolipoprotein B mRNA Editing - Products and methods for modifying apolipoprotein B mRNA editing in vivo, reducing serum LDL levels, and treating or preventing an atherogenic disease or disorder are disclosed. Such methods involve the use of a protein including APOBEC-1 or fragments thereof which can edit mRNA encoding apolipoprotein B. The protein including APOBEC-1 can be taken up by cells in the form of a delivery vehicle, such as a liposome or niosome, or directly as a chimeric protein which includes a first polypeptide that includes a protein transduction domain and a second polypeptide that includes APOBEC-1 or a fragment thereof which can edit mRNA encoding apolipoprotein B. | 11-25-2010 |
| 20110152107 | Drug Screening Via Nanpore Silicon Filters - The invention provides a porous nanoscale membrane. In one embodiment, the membrane can be used as a filtration device to screen agents that disrupt or prevent molecular interactions. In one embodiment, the membrane allows for screening agents that disrupt or prevent molecular interactions using a small sample volume with efficient high-throughput screening applications. | 06-23-2011 |
